Resistance in Escherichia coli isolates colonizing gastrointestinal tracts of dogs, cats, and their owners in Northern Kenya was investigated with an emphasis on extended-spectrum beta-lactamases (ESBLs). Totals of 47 (22%, n ‫؍‬ 216), 2 (4%, n ‫؍‬ 50), and 4 (17%, n ‫؍‬ 23) CTX-M-15-producing E. coli isolates were obtained from dogs, cats, and humans, respectively. CTX-M-15-producing E. coli isolates with identical PFGE profiles were detected in animals and humans living in the same area.
T
ransfer of resistant bacteria between humans and their dogs has been documented in various studies from the Western world (12) . There have been no such data, however, from developing African countries. Dogs have been repeatedly recognized as comprising reservoirs or sentinels for zoonotic and livestock-infecting pathogens and, as such, are useful for epidemiological monitoring in rural parts of Africa (5) . This study investigated the prevalence and molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli strains in Northern Kenya, an area inhabited mainly by nomadic herders of the Samburu, Turkana, El Molo, Rendille, and Gabra tribes. Although certain allopathic antimicrobials (mainly oxytetracycline) are occasionally used to treat livestock, veterinary medicine for small animals is virtually absent in the area (2) . As direct selective antibiotic pressure is minimized in these animals, domestic carnivores can serve as sentinels of environmental contamination.
Rectal swabs of 216 dogs, 50 cats, and 23 humans were collected into Amies medium in September and October 2009 in nine settlements in Marsabit and Samburu Districts of Northern Kenya. Swabs were plated in parallel on plain MacConkey agar (MCA) (Oxoid, United Kingdom) and MCA with cefotaxime (2 mg/liter). One lactose-fermenting colony was isolated from each plate and tested for susceptibility to 12 antimicrobial agents using the disc diffusion method (8) . Colonies obtained on cefotaximesupplemented MCA were identified by using the API test (bioMérieux, France) and examined by the double-disc synergy test (8) . The ESBL-positive E. coli isolates were tested by PCR and sequencing for (i) ESBL-coding genes bla TEM , bla CTX-M , bla SHV , and bla OXA , (ii) plasmid-mediated quinolone-resistance genes aac(6=)-Ib-cr, qepA, qnrA, qnrB, qnrC, qnrD, and qnrS, and (iii) additional antibiotic resistance genes and integrons as described previously (14) . All other methods used were described elsewhere (10) . In brief, ESBL-producing E. coli were typed and clustered by pulse-field gel-electrophoresis (PFGE) (4) and their phylogenetic groups were identified by multiplex PCR assay (6) . In isolates belonging to phylogenetic group B2, allele-specific PCR was performed to identify the O25-ST131 clone (7) . Multilocus sequence typing (MLST) determination was carried out in isolates positive by allele-specific PCR and analyzed at http:/mlst.ucc.ie/mlst/dbs /Ecoli (17) . The insertion sequence ISEcpI in the upstream region of bla genes was tested (11) . Chemical transformation of plasmids and conjugation experiments to E. coli MT102RN and Salmonella enterica serovar Typhimurium SL5325 were performed (15) . Plasmids were analyzed by S1-PFGE (1), replicon typing (3), and restriction fragment length polymorphism profiles obtained by EcoRV digestion.
A total of 267 lactose-fermenting isolates were obtained by cultivating the swabs on MCA without antibiotics. The resistance patterns of these isolates ranged from 1 (ampicillin, gentamicin, tetracycline, streptomycin, or nalidixic acid) to all 12 of the antibiotics tested. Multiresistance to ampicillin, streptomycin, sulfonamides, tetracycline, and trimethoprim-sulfamethoxazole was the most frequent phenotype.
Totals of 47 (22%, n ϭ 216), 2 (4%, n ϭ 50), and 4 (17%, n ϭ 23) ESBL-positive E. coli isolates were obtained from dogs, cats, and humans, respectively, by cultivation on cefotaxime-supplemented MCA. Resistance to amoxicillin-clavulanic acid was found in 15% and resistance to ceftazidime in 11% of the ESBLproducing isolates. Apart from resistance to beta-lactam antibiotics, these isolates showed resistance to tetracycline (100% of the ESBL-producing isolates), trimethoprim-sulfamethoxazole (100%), sulfonamides (98%), nalidixic acid (96%), ciprofloxacin (94%), gentamicin (87%), chloramphenicol (43%), and streptomycin (34%). Comparison of PFGE banding patterns clustered the ESBL-producing isolates into five groups of closely related isolates (Ͼ85% similarity) designated clusters K, L, M, N, and O ( Fig. 1) . Overall, 36 (70%) of the ESBL-producing isolates belonged to either cluster K or L. Isolates with identical PFGE profiles were detected from 8 dogs and 2 humans, and closely related (Ͼ95% similarity) isolates were found in 1 human and 1 cat sampled in the same town. Three dogs were found to harbor isolates of The findings of this study corroborate the recognized worldwide spread of CTX-M-15-producing isolates, including the O25-ST131 clone, even in very remote areas where extended spectrum cephalosporins are used very rarely (9, 13, 16) . The bla CTX-M-15 gene was found on large conjugative plasmids together with genes encoding resistance to other groups of antibiotics. Such a genetic constellation, along with the warm climate and lack of sanitary facilities in rural Africa, probably facilitates the spread of multiresistant bacteria and their transfer between humans and domestic carnivores. The relatively lower resistance rates in isolates from cats compared to the resistance rates in isolates from dogs could be explained by the different foraging behaviors of the two species. While cats may prefer hunting in the bush, dogs are probably more reliant on household leftovers and more prone to coprophagy. Such a scavenger strategy renders dogs good sentinels of environmental contamination and suitable for monitoring of local resistance patterns. Further studies are needed to specify the role of livestock, the mainstay of nomadic pastoralist communities, as well as omnipresent domestic rodents, in the epidemiology of antibiotic-resistant bacteria.
